159 related articles for article (PubMed ID: 32904711)
1. Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes.
Christensen MB; Lund AB; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK
J Endocr Soc; 2020 Sep; 4(9):bvaa097. PubMed ID: 32904711
[TBL] [Abstract][Full Text] [Related]
2. Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia.
Christensen MB; Lund A; Calanna S; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2018 Jan; 103(1):288-294. PubMed ID: 29099978
[TBL] [Abstract][Full Text] [Related]
3. GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH
Gasbjerg LS; Hartmann B; Christensen MB; Lanng AR; Vilsbøll T; Jørgensen NR; Holst JJ; Rosenkilde MM; Knop FK
Bone; 2020 Jan; 130():115079. PubMed ID: 31622777
[TBL] [Abstract][Full Text] [Related]
4. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
Bergmann NC; Lund A; Gasbjerg LS; Jørgensen NR; Jessen L; Hartmann B; Holst JJ; Christensen MB; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2019 Jul; 104(7):2953-2960. PubMed ID: 30848791
[TBL] [Abstract][Full Text] [Related]
5. The role of endogenous GIP and GLP-1 in postprandial bone homeostasis.
Helsted MM; Gasbjerg LS; Lanng AR; Bergmann NC; Stensen S; Hartmann B; Christensen MB; Holst JJ; Vilsbøll T; Rosenkilde MM; Knop FK
Bone; 2020 Nov; 140():115553. PubMed ID: 32730920
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.
Nissen A; Christensen M; Knop FK; Vilsbøll T; Holst JJ; Hartmann B
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2325-9. PubMed ID: 25144635
[TBL] [Abstract][Full Text] [Related]
7. Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.
Skov-Jeppesen K; Christiansen CB; Hansen LS; Windeløv JA; Hedbäck N; Gasbjerg LS; Hindsø M; Svane MS; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
J Clin Endocrinol Metab; 2024 Jun; 109(7):1773-1780. PubMed ID: 38217866
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study.
Skov-Jeppesen K; Veedfald S; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
Bone; 2021 Nov; 152():116065. PubMed ID: 34153529
[TBL] [Abstract][Full Text] [Related]
9. GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.
Skov-Jeppesen K; Svane MS; Martinussen C; Gabe MBN; Gasbjerg LS; Veedfald S; Bojsen-Møller KN; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
Bone; 2019 Aug; 125():178-185. PubMed ID: 31100534
[TBL] [Abstract][Full Text] [Related]
10. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
Veedfald S; Vedtofte L; Skov-Jeppesen K; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Christensen MB; Holst JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665480
[TBL] [Abstract][Full Text] [Related]
11. Effects of endogenous GIP in patients with type 2 diabetes.
Stensen S; Gasbjerg LS; Krogh LL; Skov-Jeppesen K; Sparre-Ulrich AH; Jensen MH; Dela F; Hartmann B; Vilsbøll T; Holst JJ; Rosenkilde MM; Christensen MB; Knop FK
Eur J Endocrinol; 2021 May; 185(1):33-45. PubMed ID: 33886495
[TBL] [Abstract][Full Text] [Related]
12. Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.
Dalsgaard NB; Gasbjerg LS; Helsted MM; Hansen LS; Hansen NL; Skov-Jeppesen K; Hartmann B; Holst JJ; Vilsbøll T; Knop FK
Bone; 2023 May; 170():116687. PubMed ID: 36754130
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.
Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311
[TBL] [Abstract][Full Text] [Related]
14. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.
Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hartmann B; Holst JJ; Hermansen K; Gregersen S; Starup-Linde J
Bone; 2020 Apr; 133():115230. PubMed ID: 31954199
[TBL] [Abstract][Full Text] [Related]
15. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.
Heimburger SMN; Nielsen CN; Calanna S; Holst JJ; Vilsbøll T; Knop FK; Christensen MB
Diabetes Obes Metab; 2022 Jan; 24(1):142-147. PubMed ID: 34490741
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
[TBL] [Abstract][Full Text] [Related]
19. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
[TBL] [Abstract][Full Text] [Related]
20. Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.
Lei WS; Kilberg MJ; Zemel BS; Rubenstein RC; Harris C; Sheikh S; Kelly A; Kindler JM
J Clin Transl Endocrinol; 2022 Dec; 30():100304. PubMed ID: 36110921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
